Tulrampator: A Novel AMPA Receptor Modulator
Exploring the potential of Tulrampator (CX-1632) for neurological and psychiatric disorders.
Get a Quote & SampleProduct Core Value
Tulrampator
Tulrampator, also identified by its developmental codes S-47445 and CX-1632, is a significant positive allosteric modulator (PAM) of the AMPA receptor (AMPAR). This compound is being investigated for its therapeutic potential in conditions such as major depressive disorder, Alzheimer's disease, dementia, and mild cognitive impairment.
- Researching antidepressant effects: Tulrampator has demonstrated antidepressant and anxiolytic-like effects in preclinical studies, making it a key compound for major depressive disorder adjunct therapy research.
- Neuroplasticity enhancement: As a neurotrophic and neuroplasticity promoting agent, Tulrampator shows promise in improving cognitive functions and memory, crucial for developing treatments for Alzheimer's disease treatment research.
- Mechanism of action: It enhances AMPAR activation, a mechanism that may lead to rapid-acting antidepressant benefits, potentially offering an alternative to existing treatments for neurological and psychiatric disorders.
- Investigational drug: Tulrampator is an investigational compound, vital for ongoing drug discovery efforts targeting cognitive decline and mood disorders.
Key Advantages
Advanced Neurological Support
Tulrampator's ability to modulate AMPA receptors positions it as a promising compound for advancing neuroscience research and understanding brain function.
Therapeutic Potential
With its demonstrated antidepressant and anxiolytic properties, Tulrampator is a critical asset in the pipeline for new treatments, aiding psychiatric disorder therapeutics development.
Cognitive Function Improvement
The compound's role in promoting neuroplasticity makes it a valuable tool for investigating mechanisms behind cognitive enhancement and developing therapies for mild cognitive impairment.
Key Applications
Neuroscience Research
Investigating the precise mechanisms of AMPA receptor modulation and its downstream effects on neuronal signaling and synaptic strength, supporting the use of Tulrampator positive allosteric modulator in academic and industry research.
Pharmaceutical Development
Serving as a key intermediate or API candidate in the development of novel therapeutics for neurological and psychiatric conditions, leveraging its profile as a S-47445 AMPA receptor modulator.
Cognitive Enhancement Studies
Exploring the potential for improving memory and learning in age-related cognitive decline or neurodegenerative diseases, aligning with research on cognitive enhancement compounds.
Antidepressant Research
Evaluating its efficacy and safety as a potential adjunct therapy for depression, contributing to the understanding of CX-1632 antidepressant effects in preclinical models.